Parkman Healthcare Partners as of June 30, 2025
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 88 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CVS Caremark Corporation (CVS) | 4.1 | $36M | 518k | 68.98 | |
| Insulet Corporation (PODD) | 3.8 | $33M | 106k | 314.18 | |
| Boston Scientific Corporation (BSX) | 3.5 | $30M | 283k | 107.41 | |
| Alnylam Pharmaceuticals (ALNY) | 3.5 | $30M | 92k | 326.09 | |
| Tenet Healthcare Corp Com New (THC) | 3.4 | $30M | 169k | 176.00 | |
| Cooper Cos (COO) | 3.2 | $27M | 386k | 71.16 | |
| Eli Lilly & Co. (LLY) | 3.0 | $26M | 33k | 779.53 | |
| Qiagen Nv Com Shs (QGEN) | 2.8 | $24M | 498k | 48.06 | |
| Zimmer Holdings (ZBH) | 2.5 | $22M | 240k | 91.21 | |
| Danaher Corporation (DHR) | 2.5 | $22M | 110k | 197.54 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $21M | 166k | 125.69 | |
| Stryker Corporation (SYK) | 2.3 | $20M | 50k | 395.63 | |
| Dex (DXCM) | 2.3 | $20M | 226k | 87.29 | |
| Edwards Lifesciences (EW) | 2.3 | $20M | 252k | 78.21 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.2 | $19M | 198k | 94.58 | |
| Miragen Therapeutics (VRDN) | 2.1 | $18M | 1.3M | 13.98 | |
| Iqvia Holdings (IQV) | 2.0 | $17M | 110k | 157.59 | |
| Genedx Holdings Corp Com Cl A (WGS) | 1.9 | $16M | 175k | 92.31 | |
| PerkinElmer (RVTY) | 1.7 | $15M | 157k | 96.72 | |
| Gilead Sciences (GILD) | 1.7 | $15M | 132k | 110.87 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.6 | $14M | 489k | 27.67 | |
| McKesson Corporation (MCK) | 1.5 | $13M | 18k | 732.78 | |
| BioMarin Pharmaceutical (BMRN) | 1.4 | $12M | 225k | 54.97 | |
| Travere Therapeutics (TVTX) | 1.4 | $12M | 827k | 14.80 | |
| Schrodinger (SDGR) | 1.4 | $12M | 588k | 20.12 | |
| Arcellx Common Stock (ACLX) | 1.3 | $12M | 174k | 65.85 | |
| Quidel Corp (QDEL) | 1.3 | $11M | 387k | 28.82 | |
| Outset Med Com New (OM) | 1.2 | $11M | 549k | 19.21 | |
| Mbx Biosciences (MBX) | 1.1 | $9.9M | 872k | 11.41 | |
| Xeris Pharmaceuticals (XERS) | 1.1 | $9.8M | 2.1M | 4.67 | |
| Nuvalent Inc-a (NUVL) | 1.0 | $9.1M | 120k | 76.30 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $9.0M | 1.0M | 8.96 | |
| Ptc Therapeutics I (PTCT) | 1.0 | $8.9M | 182k | 48.84 | |
| Merus N V (MRUS) | 1.0 | $8.6M | 163k | 52.60 | |
| Edgewise Therapeutics (EWTX) | 1.0 | $8.5M | 647k | 13.11 | |
| Biosante Pharmaceuticals (ANIP) | 1.0 | $8.4M | 129k | 65.25 | |
| Replimune Group (REPL) | 1.0 | $8.3M | 897k | 9.29 | |
| Rxsight (RXST) | 0.9 | $8.2M | 634k | 13.00 | |
| Syndax Pharmaceuticals (SNDX) | 0.9 | $8.1M | 868k | 9.37 | |
| Livanova SHS (LIVN) | 0.9 | $7.9M | 175k | 45.02 | |
| Upstream Bio (UPB) | 0.9 | $7.9M | 716k | 10.98 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $7.7M | 679k | 11.30 | |
| Doximity Cl A (DOCS) | 0.9 | $7.4M | 121k | 61.34 | |
| Quest Diagnostics Incorporated (DGX) | 0.8 | $7.4M | 41k | 179.63 | |
| Axogen (AXGN) | 0.8 | $7.3M | 675k | 10.85 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $7.3M | 42k | 172.60 | |
| Alphatec Hldgs Com New (ATEC) | 0.8 | $7.2M | 649k | 11.10 | |
| Castle Biosciences (CSTL) | 0.8 | $7.2M | 352k | 20.42 | |
| Mannkind Corp Com New (MNKD) | 0.8 | $7.1M | 1.9M | 3.74 | |
| Optimizerx Corp Com New (OPRX) | 0.8 | $6.9M | 507k | 13.50 | |
| Si-bone (SIBN) | 0.8 | $6.8M | 362k | 18.82 | |
| Mineralys Therapeutics (MLYS) | 0.7 | $6.3M | 464k | 13.53 | |
| Uniqure Nv SHS (QURE) | 0.7 | $6.2M | 443k | 13.94 | |
| CryoLife (AORT) | 0.7 | $6.0M | 193k | 31.10 | |
| Veracyte (VCYT) | 0.7 | $6.0M | 220k | 27.03 | |
| Certara Ord (CERT) | 0.7 | $5.9M | 500k | 11.70 | |
| Alkermes SHS Put Option (ALKS) | 0.7 | $5.7M | 200k | 28.61 | |
| Waystar Holding Corp (WAY) | 0.7 | $5.7M | 140k | 40.87 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $5.4M | 148k | 36.36 | |
| Incyte Corporation (INCY) | 0.6 | $5.1M | 75k | 68.10 | |
| Treace Med Concepts (TMCI) | 0.6 | $5.0M | 844k | 5.88 | |
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $4.9M | 600k | 8.14 | |
| Performant Finl (PHLT) | 0.6 | $4.9M | 1.2M | 4.00 | |
| Xenon Pharmaceuticals (XENE) | 0.5 | $4.7M | 150k | 31.30 | |
| CVRX (CVRX) | 0.5 | $4.6M | 789k | 5.88 | |
| Amylyx Pharmaceuticals (AMLX) | 0.5 | $4.2M | 650k | 6.41 | |
| Amicus Therapeutics (FOLD) | 0.4 | $3.5M | 609k | 5.73 | |
| Quanterix Ord (QTRX) | 0.4 | $3.4M | 516k | 6.65 | |
| Protagonist Therapeutics (PTGX) | 0.4 | $3.4M | 62k | 55.27 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $3.3M | 500k | 6.50 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.4 | $3.2M | 913k | 3.45 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $3.1M | 818k | 3.73 | |
| Inspiremd (NSPR) | 0.3 | $2.8M | 1.2M | 2.27 | |
| Vera Therapeutics Cl A (VERA) | 0.3 | $2.7M | 116k | 23.56 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.3 | $2.7M | 270k | 9.92 | |
| Nurix Therapeutics (NRIX) | 0.3 | $2.6M | 228k | 11.39 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $2.5M | 8.8k | 287.35 | |
| Urogen Pharma (URGN) | 0.3 | $2.4M | 177k | 13.70 | |
| Apogee Therapeutics (APGE) | 0.3 | $2.4M | 55k | 43.43 | |
| Precigen (PGEN) | 0.3 | $2.2M | 1.5M | 1.42 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.2 | $2.1M | 73k | 28.76 | |
| Pulmonx Corp (LUNG) | 0.2 | $1.6M | 605k | 2.59 | |
| Ardelyx (ARDX) | 0.1 | $1.2M | 301k | 3.92 | |
| Annexon (ANNX) | 0.1 | $970k | 404k | 2.40 | |
| Atyr Pharma Com New (ATYR) | 0.1 | $761k | 150k | 5.07 | |
| 908 Devices (MASS) | 0.1 | $713k | 100k | 7.13 | |
| Entera Bio SHS (ENTX) | 0.1 | $676k | 356k | 1.90 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.0 | $256k | 155k | 1.65 |
